Pine Labs IPO Review 2025 – Should You Apply or Avoid?

The highly anticipated Pine Labs IPO is finally here! One of India’s most prominent fintech and merchant payment companies, Pine Labs is all set to make its Dalal Street debut in November 2025. Backed by Temasek, Mastercard, PayPal, and Peak XV Partners (formerly Sequoia India), this IPO is being closely tracked as a potential game-changer for India’s digital payment ecosystem.
Pine Labs IPO Dates and Key Details
| Event | Date / Information |
| IPO Open Date | November 7, 2025 (Friday) |
| IPO Close Date | November 11, 2025 (Tuesday) |
| Basis of Allotment | November 12, 2025 (Wednesday) |
| Credit to Demat | November 13, 2025 (Thursday) |
| Listing Date | November 14, 2025 |
| Price Band | ₹210 – ₹221 per share |
| Lot Size | 67 shares |
| Issue Type | Fresh Issue + Offer for Sale |
| Fresh Issue Size | 9.41 crore shares (₹2,080 crore) |
| Offer for Sale (OFS) | 8.23 crore shares (₹1,819 crore) |
| Total Issue Size | ₹3,899.91 crore |
| Listing Exchange | BSE & NSE |
About Pine Labs Limited
Founded in 1998, Pine Labs has evolved from a POS hardware provider to a software-first fintech platform serving more than 0.95 million merchants across India, Southeast Asia, and the Middle East. The company processes over 5.6 billion transactions annually, offering solutions for digital payments, EMI, prepaid cards, and loyalty programs.
Today, Pine Labs stands as a B2B fintech pioneer, providing digital infrastructure and merchant solutions that help businesses streamline transactions, credit, and customer engagement.
Objects of the Issue
Proceeds from the fresh issue worth ₹2,080 crore will be utilized for:
- Business expansion and technology development
- Repayment or prepayment of borrowings (₹532 crore earmarked)
- General corporate purposes
This fund infusion will strengthen the balance sheet and reduce financial leverage.
Key Management Team
- Amrish Rau – CEO (Former PayU India)
- Sameer Maheshwary – CFO (Former Airtel Money)
- Lokvir Kapoor – Founder & Chairman
Pine Labs’ board includes key representatives from Temasek, Mastercard, PayPal, and Peak XV Partners, ensuring top-tier governance.
Financial Performance (FY23–FY25)
| Particulars (₹ Million) | FY23 | FY24 | FY25 |
| Revenue from Operations | 15,976 | 17,695 | 22,743 |
| EBITDA (Adjusted) | 1,968 | (6,910) | 3,567 |
| Net Profit / (Loss) | (2,652) | (3,419) | (998) |
| EBITDA Margin (%) | 12.3% | -10.0% | 15.7% |
| Total Borrowings | ₹888.7 Cr | ₹836.6 Cr (Aug 2025) | |
| Cash & Bank Balances | — | — | ₹9,000 Cr |
Highlights:
- FY25 revenue grew 28.5% YoY
- Loss narrowed by 70% YoY
- Positive EBITDA margin at 15.7%
- Strong liquidity with ₹9,000 Cr cash reserves
Valuation Metrics
| Metric | Value / Estimate |
| P/E (FY25) | Not applicable (loss-making) |
| Forward P/E (FY26E) | 80–100× (estimated PAT ₹350–₹500 Cr) |
| EV/Sales (FY25) | ~8.5× |
| Book Value per Share | ₹42–₹45 |
| P/B Ratio | 4.8×–5.2× (at ₹221) |
| OPM (FY25) | 15.7% |
Competitors
| Company | Segment | Status |
| Paytm | B2C Fintech | Still loss-making |
| Razorpay | B2B Payments | Profitable (unlisted) |
| Adyen (Global) | Payment Processor | 20%+ EBITDA margin |
Pine Labs’ B2B merchant focus offers better margin stability and lower customer churn compared to B2C fintech players like Paytm.
Strengths and Risks
✅ Strengths
- Strong backing from global investors (Temasek, PayPal, Mastercard)
- ₹9,000 Cr cash reserves for growth and acquisitions
- Positive EBITDA margin and nearing profitability
- Scalable SaaS-based merchant solutions across multiple geographies
⚠️ Risks
- Regulatory challenges under RBI’s fintech framework
- UPI growth may impact card-based transactions
- Competitive landscape in the digital payment ecosystem
- Short-term borrowings (~₹836 Cr) add slight leverage pressure
Conclusion – Should You Apply for Pine Labs IPO?
Pine Labs is among the few Indian fintech companies transitioning towards profitability while maintaining strong institutional backing. The IPO’s Fresh Issue + OFS structure supports balance sheet strengthening and investor liquidity.
However, since a portion of proceeds will go toward debt repayment rather than aggressive expansion, short-term listing gains may be limited.


